Skip to Content

C170 (Darifenacin Hydrobromide Extended-Release 7.5 mg (base))

Pill with imprint C170 is Yellow, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg (base). It is supplied by Par Pharmaceutical, Inc..

Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for C170

Darifenacin Hydrobromide Extended-Release

Imprint:
C170
Strength:
7.5 mg (base)
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical, Inc.
National Drug Code (NDC):
10370-0170

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide